Bzl-D-Val-OMe*HCl

Bzl-D-Val-OMe*HCl is a chiral valine-derived amino acid methyl ester hydrochloride in which the amino group is benzyl-protected (Bzl) and the carboxyl functionality is present as a methyl ester, with D-configuration at the α-carbon. The benzyl carbamate-like protection strategy and the esterified C-terminus together create a peptide-coupling-compatible, orthogonally protected building block that can be activated at the carboxylate while retaining the protected amine. The hydrochloride salt form improves handling of the amino functionality during synthesis and can influence solubility in polar organic solvents used for peptide chemistry. The combination of stereochemical definition, protected amine, and ester activation handle supports downstream conversion to protected amino acid derivatives, peptide fragments, and chiral intermediates for fine chemical and biochemical research workflows.

1. Protected Amino Acid Chemistry

Bzl-D-Val-OMe*HCl is applied in protected amino acid synthesis where the benzyl-protected amino functionality and the methyl ester C-terminus enable controlled peptide coupling chemistry. The D-stereocenter provides stereochemical fidelity for generating D-valine-containing sequences and for preparing chiral intermediates used in stereodefined fragment assembly. The ester can be transformed into activated carboxyl derivatives for amide bond formation, while the benzyl-protecting group strategy supports orthogonal deprotection planning in multistep routes. Downstream, the compound serves as a practical intermediate for producing protected D-valine building blocks and for constructing stereochemically defined peptide analogs used in chemical synthesis and biochemical research.

2. Peptide Synthesis Building Blocks

Bzl-D-Val-OMe*HCl is suitable for peptide synthesis workflows requiring a D-amino acid residue with a protected amine and an esterified carboxyl group. The benzyl-protected nitrogen can be maintained during coupling steps, while the methyl ester moiety can be converted into coupling-ready forms that participate in amide bond formation toward both linear peptide fragments and protected peptide intermediates. The defined D-configuration supports incorporation into peptidic scaffolds where resistance to proteolysis or altered conformational preferences are investigated through stereochemical variation. Resulting peptide products and protected fragments can then be carried forward to sequence assembly, fragment ligation, or stepwise deprotection strategies consistent with peptide chemistry manufacturing and research synthesis.

3. Chiral Intermediate For SAR Studies

Bzl-D-Val-OMe*HCl is used in chiral synthesis and structure-activity relationship studies where stereodefined amino acid derivatives are required to map stereochemical contributions to binding or recognition. The D-valine backbone, combined with the protected amine and methyl ester handle, allows systematic preparation of analog libraries differing at stereocenters or C-terminal functionality. The benzyl-protection strategy supports controlled functional group manipulations, including conversion of the ester to carboxylate derivatives and subsequent coupling into larger scaffolds. Downstream, the compound can be employed to generate stereochemically characterized fragments for medicinal chemistry exploration, peptidomimetic construction, and SAR-driven analog refinement without losing the stereochemical information encoded at the α-carbon.

4. Side-Chain Functionalization Routes

Bzl-D-Val-OMe*HCl can be applied in amino acid modification strategies that require a protected D-valine platform for later functional group elaboration. The valine side chain provides an isopropyl group that can be leveraged as a hydrophobic element when incorporated into peptides or peptidomimetics, while the protected amine and esterified carboxyl group provide synthetic handles for stepwise transformations. The methyl ester can be hydrolyzed or converted to alternative protected carboxyl forms depending on the intended coupling or conjugation step, enabling controlled downstream derivatization of the C-terminus. Resulting derivatives can feed into chemical biology probes, conformationally tuned peptide analogs, and synthetic organic chemistry routes where stereodefined amino acid intermediates are required.

5. Pharmaceutical Intermediate Preparation

Bzl-D-Val-OMe*HCl is relevant to pharmaceutical intermediate preparation and fine chemical synthesis where protected amino acid esters serve as controllable inputs for manufacturing-grade peptide fragments and chiral building blocks. The hydrochloride salt form supports reproducible handling of the protected amino functionality in process-oriented workflows, while the benzyl-protection pattern and ester group enable predictable transformations during intermediate conversion. The defined D-stereochemistry supports consistent incorporation into stereopure sequences and downstream formation of protected carboxylic acid derivatives for controlled coupling steps. After conversion into appropriate activated or deprotected forms, the compound can be used to build stereochemically defined intermediates for peptide-based materials, peptidomimetic scaffolds, and other industrially manufactured chiral fine chemicals.

6. Chemical Biology And Bioconjugation

Bzl-D-Val-OMe*HCl is suitable for chemical biology applications that require incorporation of a D-valine residue into labeled or conjugatable peptide constructs. The protected amine and ester functionality support preparation of peptide segments that can be further functionalized at the termini for conjugation strategies, including controlled deprotection to expose reactive handles for subsequent coupling. The D-configuration can be used to tune stability and conformational behavior of peptide-based probes, which is often important for labeling experiments and biomolecular interaction studies. Downstream, the compound can contribute to the assembly of stereodefined peptide conjugates and intermediate fragments used in biochemical research and applied molecular design.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides